Stock Track | Summit Therapeutics Soars 5.33% After Hours on Insider Share Purchases

Stock Track10-24

Summit Therapeutics PLC (SMMT) experienced a significant after-hours surge on Thursday, with its stock price climbing 5.33%. This sudden increase came following reports of insider share purchases by key company executives.

According to recent filings, two high-ranking officials at Summit Therapeutics have acquired common shares of the company. Anand Bhaskar, the Chief Accounting Officer, and Robert W. Duggan, the Co-Chief Executive Officer and Director, both reported purchases of company stock. The exact number of shares and the purchase prices were not immediately disclosed in the news briefs.

Insider buying is often viewed positively by investors, as it can signal management's confidence in the company's future prospects. These purchases by Summit Therapeutics' executives may have sparked optimism among after-hours traders, leading to the stock's significant uptick. As the market digests this information, investors will be watching closely to see if this insider activity translates into sustained gains for the biopharmaceutical company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112302045?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-24 04:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112302045","market":"hk","top_or_hot":-1,"title":"Stock Track | Summit Therapeutics Soars 5.33% After Hours on Insider Share Purchases","media":"Stock Track","content":"<p>Summit Therapeutics PLC (SMMT) experienced a significant after-hours surge on Thursday, with its stock price climbing 5.33%. This sudden increase came following reports of insider share purchases by key company executives.</p>\n\n<p>According to recent filings, two high-ranking officials at Summit Therapeutics have acquired common shares of the company. Anand Bhaskar, the Chief Accounting Officer, and Robert W. Duggan, the Co-Chief Executive Officer and Director, both reported purchases of company stock. The exact number of shares and the purchase prices were not immediately disclosed in the news briefs.</p>\n\n<p>Insider buying is often viewed positively by investors, as it can signal management's confidence in the company's future prospects. These purchases by Summit Therapeutics' executives may have sparked optimism among after-hours traders, leading to the stock's significant uptick. As the market digests this information, investors will be watching closely to see if this insider activity translates into sustained gains for the biopharmaceutical company.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Summit Therapeutics Soars 5.33% After Hours on Insider Share Purchases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Summit Therapeutics Soars 5.33% After Hours on Insider Share Purchases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-24 04:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Summit Therapeutics PLC (SMMT) experienced a significant after-hours surge on Thursday, with its stock price climbing 5.33%. This sudden increase came following reports of insider share purchases by key company executives.</p>\n\n<p>According to recent filings, two high-ranking officials at Summit Therapeutics have acquired common shares of the company. Anand Bhaskar, the Chief Accounting Officer, and Robert W. Duggan, the Co-Chief Executive Officer and Director, both reported purchases of company stock. The exact number of shares and the purchase prices were not immediately disclosed in the news briefs.</p>\n\n<p>Insider buying is often viewed positively by investors, as it can signal management's confidence in the company's future prospects. These purchases by Summit Therapeutics' executives may have sparked optimism among after-hours traders, leading to the stock's significant uptick. As the market digests this information, investors will be watching closely to see if this insider activity translates into sustained gains for the biopharmaceutical company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SMMT","symbol_name":"Summit Therapeutics PLC","start_time":0,"source_url":"","article_id":"1112302045","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112302045","pubTimestamp":1761252145,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Summit Therapeutics PLC (SMMT) experienced a significant after-hours surge on Thursday, with its stock price climbing 5.33%. This sudden increase came following reports of insider share purchases by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SMMT":"Summit Therapeutics PLC"},"translate_title":"个股追踪|Summit Therapeutics盘后大涨5.33%因内部人士购股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMMT":1},"content_text":"Summit Therapeutics PLC (SMMT) experienced a significant after-hours surge on Thursday, with its stock price climbing 5.33%. This sudden increase came following reports of insider share purchases by key company executives.\nAccording to recent filings, two high-ranking officials at Summit Therapeutics have acquired common shares of the company. Anand Bhaskar, the Chief Accounting Officer, and Robert W. Duggan, the Co-Chief Executive Officer and Director, both reported purchases of company stock. The exact number of shares and the purchase prices were not immediately disclosed in the news briefs.\nInsider buying is often viewed positively by investors, as it can signal management's confidence in the company's future prospects. These purchases by Summit Therapeutics' executives may have sparked optimism among after-hours traders, leading to the stock's significant uptick. As the market digests this information, investors will be watching closely to see if this insider activity translates into sustained gains for the biopharmaceutical company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112302045","isCrawlerRequest":true}